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Abrogation of TGFb Signaling in T Cells
Leads to Spontaneous T Cell Differentiation
and Autoimmune Disease
Sanford et al., 1997), thus making the study of the role
of TGFb2 and 3 in immune regulation in vivo very difficult.
While an autoimmune phenotype in TGFb1 knockout
mice has been ascribed largely to the presence of acti-
vated CD41 T cells (Christ et al., 1994; Diebold et al.,
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1995; Letterio et al., 1996), the mechanism leading to
the activation of these T cells and the acquisition of their
effector function (e.g., cytokine production) has not yetSummary
been identified. Spontaneous upregulation of MHC class
II and I on multiple tissues was observed to precedeTargeted mutation of TGFb1 in mice demonstrated
lymphocyte infiltration into these tissues and was sug-that TGFb1 is one of the key negative regulators of
gested to play a crucial role in the initiation of the autoim-immune homeostasis, as its absence leads to activa-
mune response in TGFb1 knockout mice (Geiser et al.,tion of a self-targeted immune response. Neverthe-
1993). However, it was unclear whether uncontrolledless, because of the highly pleiotropic properties of
activation of T cells and autoimmune disease in TGFb1TGFb and the presence of TGFb receptors on most
knockout mice arises from the lack of control by TGFb1cell types, its biologic role in the regulation of immune
on the expression of MHC molecules, thereby leadinghomeostasis is not yet understood. To limit the conse-
to improper antigen presentation and T cell activation,quences of TGFb effects to a single cell type, we devel-
or from the loss of direct control by TGFb1 on the mainte-oped a transgenic approach to abrogate the TGFb
nance of T cell homeostasis.response in key immune cells. Specifically, we ex-
Numerous in vitro studies have also delineated a com-pressed a dominant-negative TGFb receptor type II
plicated and in some aspects controversial role of TGFbunder a T cell±specific promoter and created a mouse
in immune regulation (Letterio and Roberts, 1998). Onemodel where signaling by TGFb is blocked specifically
of the major difficulties in defining a specific role forin T cells. Using this transgenic model, we show that
TGFb in immune regulation comes from the widespreadT cell homeostasis requires TGFb signaling in T cells.
expression of TGFb and its receptors (Miyazono et al.,
1994), which makes it difficult to separate the effects ofIntroduction
TGFb on T cells from its effects on antigen-presenting
cells or on nonlymphoid cells. In order to study a roleTGFb is one of the most widely distributed cytokines
of TGFb signaling in the regulation of T cells in vivo andthat acts on virtually all cell types and mediates highly
in vitro, we have overcome the shortcomings of thepleiotropic functions. All three isoforms of TGFb in mam-
above mentioned studies by creating a model in whichmals share a high level of homology and use the same
signaling by all three endogenously produced isoforms
receptor complex for signaling to exert a seemingly re-
of TGFb can be blocked selectively in T cells. This strat-
dundant set of functions in vitro (Arai et al., 1990; Mas-
egy employs the expression of a dominant-negative
sague, 1990). TGFb1 is a predominant TGFb isoform in form of TGFb receptor type II (dnTGFbRII). This molecule
lymphoid organs and is the major TGFb species consti- has a truncated intracellular kinase domain, and al-
tutively present in serum. Conversely, TGFb2 and 3 are though it binds all three isoforms of TGFb, it is incapable
predominantly expressed in mesenchymal tissues and of mediating any signal transduction (Wieser et al., 1993;
bones (Pelton et al., 1989; Millan et al., 1991; Schmid Wrana et al., 1994). By the use of different cell-specific
et al., 1991). Differential tissue distribution of different promoters, this approach has been successfully used
isoforms of TGFb as well as different affinity of these to selectively block TGFb signaling in a variety of cell
isoforms for the TGFb receptor (Miyazono et al., 1994) types (e.g., mammary cells [Bottinger et al., 1997], osteo-
may account for different physiological roles of TGFb blasts [Erlebacher et al., 1998], and skin cells [Amendt
isoforms in vivo. Accordingly, TGFb1 knockout (KO) et al., 1998]). In order to address the role of TGFb in the
mice are able to survive only until 3±4 weeks of age, regulation of T cell differentiation and activation, we
when they experience spontaneous activation of a self- adopted this strategy and created a mouse transgenic
targeted immune response that leads to their death for the expression of a dominant-negative form of TGFb
(Shull et al., 1992; Kulkarni et al., 1993). Since only ap- receptor type II expressed under the control of the mu-
proximately half of the TGFb1 knockout mice are born rine CD4 promoter. This particular CD4 transgenic con-
(Kulkarni et al., 1995), TGFb1 is, apparently, also re- struct lacks the CD8 silencer, which therefore allows the
quired for a number of developmental processes, in expression of the transgene in CD41 as well as CD81 T
particular, for hematopoiesis (Martin et al., 1995). TGFb2 cells (Sawada et al., 1994). The resulting transgenic mice
and 3 knockout animals experience a different set of have impaired TGFb signaling specifically and exclu-
major developmental defects resulting in malformation sively in T cells. These mice developed autoimmune
of bones and internal organs, which leads to embryonic disease characterized by inflammatory infiltration in sev-
lethality (Kaartinen et al., 1995; Proetzel et al., 1995; eral organs and the presence of circulating autoimmune
antibodies. In addition, in the absence of TGFb signaling,
most of the T cells differentiate spontaneously into Type* To whom correspondence should be addressed (e-mail: richard.
flavell@yale.edu). 1/Type 2 cytokine secreting cells. We conclude that T
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Figure 1. Generation and Characterization of CD4-dnTGFbRII Transgenic Mice
(A) Schematic representation of CD4-dnTGFbRII construct. The open box represents extracellular and transmembrane portions of human
TGFb receptor type II between nucleotides 27 and 1573 followed by a stop codon. Primers used for RT±PCR analysis of the transgene
expression in transgene-positive mice are also shown.
(B) RT±PCR was performed using the primers indicated in (A) to show the spliced mRNA species of the transgene. Total RNA was extracted
from the thymuses of (1) transgene-negative mouse and (2 and 3) progeny of different transgenic founder mice.
(C) Magnetic bead±purified CD41, CD81 or unfractionated spleen cells from Tg1 or Tg2 littermates were stimulated with either anti-CD3/anti-
CD28 mAbs (5 mg/ml each) (for CD41 and CD81 cells) or LPS (10 mg/ml) (for total splenocytes) in the presence (plus) or absence (minus) of
huTGFb1 (3 ng/ml). After 30 min of culture, total cell lysates were prepared and subjected to gel electrophoresis followed by Western blotting
with anti-phospho-Smad2-specific Ab, and blots were stripped and subsequently reprobed with anti-Smad2 mAb and b-actin Ab.
(D) Purified CD41 or CD81 from 6-week-old Tg1 and Tg2 mice were stimulated with anti-CD3 mAb (5 mg/ml) and anti-CD28 (10 mg/ml) precoated
plastic wells in 96-well plates for 72 hr in the presence or absence of 3 ng/ml of TGFb1, TGFb2, or TGFb3 (for CD41), or TGFb1 for CD81 or
B2201 cells. B2201 cells were stimulated with 10 mg/ml of LPS for 48 hr. One microcurie per well of [3H]thymidine was added for the last 8
hr of culture. One representative experiment out of six experiments is shown. An asterisk indicates statistically significant decrease (p , 0.01)
in [3H]thymidine incorporation in the presence of exogenously added TGFb.
cell homeostasis and prevention of inflammatory infiltra- Using DNA microinjection into (C57BL/6xC3H)F1 fertil-
ized oocytes, we obtained six transgene-positive mice.tion require TGFb signaling in T cells.
All pups appeared normal at 2 weeks of age, but two
of the transgene-positive pups died suddenly between
Results 2 and 3 weeks of age, thus not allowing us to examine
causes of their death. One more transgene-positive
Generation of the CD4-dnTGFbRII Transgenic Mice mouse died at 4 weeks of age and postmortem examina-
Dominant-negative TGFb receptor type II has been pre- tion revealed severe multiorgan mononuclear infiltration;
viously shown to block TGFb signaling when expressed the expedited death of that animal did not allow us to
at a sufficiently high level by interfering with the assem- investigate the pattern of transgene expression. Three
bly of a functional signaling complex consisting of TGFb remaining transgene-positive mice appeared healthy
and type II and type I TGFb receptors (Chen et al., 1993; and were bred; their progeny was used to identify trans-
Wieser et al., 1993). In order to study the role of TGFb in genic lines expressing a functional dominant-negative
the regulation of T lymphocytes exclusively, we created TGFb receptor type II. Using RT±PCR with primers span-
transgenic mice expressing dominant-negative TGFb ning the z2.4 kb intron region of the CD4 promoter
receptor type II (dnTGFbRII) under the control of the construct, we were able to identify two lines that ex-
CD4 promoter (Figure 1A). This particular CD4 promoter pressed spliced mRNA encoding the dnTGFbRII (Figure
construct lacks the CD8 silencer, thus allowing the ex- 1B). Since both of these transgenic lines demonstrated a
pression of a particular transgene in CD81 as well as very similar phenotype, we present the results obtained
only from one of these transgenic lines. We testedCD41 T cells but not in B cells (Sawada et al., 1994).
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Figure 2. Autoimmune Manifestations in CD4-
dnTGFbRII Tg1 Mice
(A) Lung sections (top panel, 2003 magnifica-
tion) reveal perivascular infiltration of mono-
nuclear cells in lungs of 5-month-old CD4-
dnTGFbRII transgenic mice (right panel).
Colon sections (bottom panel, 1003) exhibit
accumulation of inflammatory cells in lamina
propria and intestinal glands. Hematoxylin
and eosin staining of tissues from Tg2 lit-
termate mice are shown as a control (left
panel).
(B) Nuclear protein extract from murine T lym-
phocytes was separated on a 10% SDS gel,
transferred to the PVDF membrane, and cut
into strips; each strip was blotted with 1:150
dilution of serum from an individual 5-month-
old mouse. After washing, strips were devel-
oped using mouse IgG-specific HRP-labeled
rabbit Abs. Sera from two Tg2 and seven Tg1
mice have been analyzed.
(C) Frozen kidney sections from transgene-
negative (left) or transgene-positive mice
(right) were stained with FITC-labeled goat
anti-mouse IgG. Three mice per group have
been analyzed and the representative micro-
scopic view (3003 magnification) is pre-
sented.
whether the transgenic lines expressed dnTGFbRII on CD4-dnTGFbRII mice relative to B cells from wild-type
mice. These results indicated that the level of dnTGFbRIIT cells at a level sufficient to block all TGFb signaling.
To do this we used an approach based on the estab- expressed was sufficient to block TGFb signaling through
functional TGFb receptor in T cells exclusively. We nextlished TGFb signaling mechanism in which binding of
TGFb to the functional TGFb receptor type II leads to tested whether the dnTGFbRII transgene could interfere
with the known ability of TGFb to inhibit T cell functionsthe phosphorylation of the signaling molecule Smad2
on Ser465/467 residues (Abdollah et al., 1997). As can such as proliferation. As can be seen from Figure 1D,
as expected (Kehrl et al., 1986), proliferation of CD41be seen from Figure 1C, there is a constitutive level of
phosphorylated Smad2 present in CD41 and CD81 cells and CD81 T cells in response to CD3 and CD28 cross-
linking was dramatically inhibited by TGFb1; at the samefrom transgene-negative littermates without any addi-
tion of exogenous TGFb to culture medium, presumably time, both T cell subsets from CD4-dnTGFbRII mice
were refractory to the inhibitory effects of TGFb1. Onas a result of TGFb present in serum, stimulating these
cells. The level of phosphorylation of Smad2 molecule the other hand, LPS-induced proliferation of B cells from
CD4-dnTGFbRII mice was inhibited by TGFb1 to theis however increased further after culture with 3 ng/ml
of TGFb1 for 30 min. In contrast, there was no detectable same extent as proliferation of B cells from transgene-
negative littermates. Thus, as expected B lymphocytesphospho±Smad2 present in CD41 and CD81 T cells from
transgene-positive animals with or without addition of not expressing dnTGFbRII are susceptible to the in-
hibitory properties of TGFb. We also tested whether TTGFb1 to the culture medium. As expected, since the
transgene is only T cell specific, there was no change cells from CD4-dnTGFbRII mice are resistant to other
isoforms of TGFb, which could be present in tissuesin the levels of phosphorylated Smad2 in B cells from
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Table 1. Phenotype of Mononuclear Cells in the Peripheral Lymphoid Organs of 5-month-old CD4-dnTGFbRII Transgene-Positive and
-Negative Mice
Spleen Lymph Node
Tg2 Tg1 Tg2 Tg1
Total Cell Number 51.3 6 18.6 85.5 6 12.0* 11.5 6 6.1 39.0 6 12.7*
CD41 16.4 6 2.6 12.7 6 1.8 26.7 6 2.1 23.0 6 1.4
CD81 13.1 6 0.8 11.0 6 1.4 22.0 6 1.7 26.5 6 2.1
B2201 59.0 6 1.7 40.0 6 1.4* 49.0 6 4.6 49.0 6 1.4
Mac-11Gr-12 1.4 6 0.8 1.3 6 0.4 1.0 6 0.0 1.0 6 0.0
NK1.11/CD41 9.2 6 2.8 15.0 6 1.4 15.0 6 1.7 18.5 6 2.1
CD62LhighCD44low/CD41 54.3 6 4.5 12.5 6 2.1* 57.0 6 14.7 16.5 6 0.7*
CD251/CD41 5.3 6 1.5 15.0 6 2.8* 7.7 6 2.9 15.0 6 7.1*
CD62LhighCD44low/CD81 37.7 6 7.8 3.0 6 2.8* 55.7 6 19.1 3.0 6 1.4*
CD251/CD81 18.7 6 5.1 26.5 6 13.4 3.7 6 2.1 6.0 6 2.8
* Indicates statistically significant (p , 0.05) difference between the particular measurement for the Tg1 versus Tg2 mice. Five 5-month-old
mice per group have been analyzed and data are presented as an average 6 SD for each group.
infiltrated by T cells. As could be seen from the same or both T cells and B cells was the cause of autoantibody
secretion. In order to test whether lack of TGFb signalingfigure, again as expected (Cousins et al., 1991; Qian et
al., 1996), proliferation of CD41 cells from wild-type mice in T cells is sufficient for induction of autoantibody se-
cretion, we tested the serum of CD4-dnTGFbRII micewas inhibited by TGFb2 and 3 to the same extent as by
TGFb1. At the same time, transgenic CD41 cells were for the presence of autoantibodies. As can be seen from
Figure 2B, Western blots of nuclear protein extract usingcompletely resistant to inhibition by TGFb3. There was,
however, slight inhibition of proliferation by TGFb2, serum from 5-month-old transgene-positive and -nega-
tive littermates revealed the presence of autoreactiveprobably due to the 10-fold lower affinity of TGFb2 for
TGFbRII than of TGFb1 or TGFb3 for the same receptor antibodies in sera of Tg1 but not Tg2 mice. Antinuclear
antibody reactivity varied from mouse to mouse, indicat-(Miyazono et al., 1994). These experiments further con-
firm that there is a sufficient level of dnTGFbRII ex- ing that the absence of TGFb signaling in T cells did not
lead to the appearance of a specific immune response topressed in T cells from transgenic animals to block the
action of TGFb. a dominant antigen. Since the presence of autoimmune
antibodies frequently leads to formation of immune
complexes and their deposition in kidney glomeruliDevelopment of Autoimmune Inflammatory Disease
in CD4-dnTGFbRII Mice in the Absence (Dixon et al., 1978), we tested whether this process oc-
curred in CD4-dnTGFbRII transgenic mice. As can beof TGFb-Mediated Regulation of T Cells
Progeny of mice from two transgenic lines that ex- seen from Figure 2C, specific staining of frozen kidney
sections with FITC-labeled anti-mouse IgG serum re-pressed functional dnTGFbRII lived without any detect-
able problems until 3±4 months of age, when they began vealed IgG deposits in kidney glomeruli of transgene
positive mice but not of their wild-type littermates.displaying signs of sickness, wasting, and diarrhea.
Upon histological examination of tissues from these
mice, we observed mononuclear cell infiltration of multi- Spontaneous Activation of T Cells
in CD4-dnTGFbRII Mice In Vivople organs. Specifically, as can be seen from Figure
2A, marked-to-severe inflammatory bowel disease was In order to understand how all these histopathological
changes are brought about, we focused on the analysespresent in all transgene-positive but not transgene-neg-
ative mice analyzed. There was moderate-to-severe in- of T cells, that is, the cells rendered insensitive to control
of TGFb in these mice. Phenotypic analyses of cellsfiltration of mucosal propria, subglandular propria, and
to a lesser extent muscularis and perivascular subse- in the lymphoid organs of these animals revealed an
increase in total cell numbers with an especially dra-rosa with dense infiltrates of lymphocytes, macrophages,
and plasma cells. In addition, there was associated dis- matic increase observed in lymph nodes, which exhib-
ited a 3-fold increase (Table 1). Thymuses of 5-month-tortion of crypt architecture, crypt abscesses, and su-
perficial thinning and compensatory hyperplasia in crypt old mice were completely involuted as judged by cellular
composition and histological appearance, and only thy-bases. Lungs of transgenic animals had focal perivascu-
lar and intraalveolar infiltration of lymphocytes and mac- mic lymph nodes were detectable in the area where the
thymus is normally present (data not shown). Neverthe-rophages. In the liver there were clusters of macro-
phages and lymphocytes located in parenchyma and less, cellular composition of lymphoid organs from CD4-
dnTGFbRII mice was not much different from that ofadjacent to blood vessels. Mild infiltration was also ob-
served in stomach, duodenum, pancreas, and kidney of wild-type littermates (Table 1). The percentage of B cells
was decreased in the spleen, although the total numbertransgene-positive mice (data not shown). None of these
changes were observed in transgene-negative litter- of splenic B cells was in fact not changed. The most
dramatic alteration in the phenotype of the lymphoidmates.
TGFb KO mice have circulating autoreactive antibod- compartment could be seen in the phenotype of T cells;
as can be seen from Figure 3, there were almost noies (Yaswen et al., 1996), but because TGFb is so pleio-
tropic, it was not clear whether disregulation of T cells CD62LhighCD44low naive T cells remaining in the lymphoid
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Figure 3. T Lymphocytes in Old CD4-
dnTGFbRII Tg1 Mice Are of Activated/Mem-
ory Phenotype
Spleen cells from 5-month-old Tg2 (left panel)
or Tg1 (right panel) littermates were analyzed
by flow cytometry for the CD62L and CD44
expression on either CD41 (top panel) or
CD81 (bottom panel) T cells. Five mice per
group have been analyzed individually and
results of the analyses of a representative
individual mouse per group are presented.
Similar results were obtained using lymph
node cells.
organs of Tg1 animals. As judged by the staining for mostly IL-2 in a 24 hr period, cells from Tg1 mice pro-
duced both IFNg and IL-4. In order to determine theCD25 and CD69, only z20% of T cells in CD4-dnTGFbRII
mice were positive for these markers (Table 1) and hence proportion of T cells capable of cytokine production, we
performed intracellular cytokine staining of T cells fromwere activated; since more then 90% of the T cells were
CD44high, we conclude that the most of the T cells were 5-month-old mice. As Figure 5B demonstrates, in con-
trast to T cells from Tg2 mice, which had only few CD41memory cells.
In order to understand the reason for such changes and CD81 cells capable of IFNg and IL-4 production,
all CD81 T cells from Tg1 mice were capable of IFNgin the phenotype of T cells, we first had to rule out the
possibility that T cell development was abnormal in the secretion, and the majority of CD41 T cells were capable
of Th1 and/or Th2 cytokine production. It is interestingabsence of TGFb signaling. As can be seen from Figure
4A, the analysis of very young 4-week-old transgenic to note that under experimental conditions, the percent-
age of T cells from Tg2 mice that was capable of effectormice revealed normal thymic cellularity and subset dis-
tribution, and in the periphery there were also no cytokine secretion was smaller than the percentage of
T cells that carries activated/memory markers. On thechanges in the distribution of cellular subsets. Still, even
at this age CD41 and CD81 T cells from Tg1 mice already other hand, most of the cells from Tg1 mice were capa-
ble of effector cytokine secretion. These observationsdisplayed a decrease in the percentage of cells with a
naive CD62highCD44low phenotype (Figure 4B), relative to indicated increased activation/differentiation of T cells
in the absence of TGFb signaling.T cells from Tg2 littermates (e.g., 53.7% 6 4.2% versus
70.6% 6 2.2% for CD41 T cells in lymph nodes of Tg1
versus Tg2 mice). This process of loss of naive cells and Increase in the Level of T Cell±Dependent
acceleration in appearance of cells with the activated/ Immunoglobulin Secretion
memory phenotype was a gradual process in CD4- in CD4-dnTGFbRII Mice
dnTGFbRII mice and was observed to accelerate as a Since CD4-dnTGFbRII mice develop the ability to secret
function of age in these mice (data not shown). autoreactive IgG antibodies and display T cells with an
acquired Th1 and Th2 phenotype, it suggests that there
could be an increase in the levels of T cell±dependentT Cells from CD4-dnTGFbRII Mice Spontaneously
Differentiate In Vivo into Effector antibody secretion. We therefore assessed how the ab-
rogation of TGFb signaling in T cells affected overallCytokine±Producing Cells
We wanted to determine next whether the increase in serum immunoglobulin levels. As can be seen from Fig-
ure 6, while serum levels of T cell±independent immuno-the percentage of cells with the activated/memory phe-
notype in transgenic animals was also associated with globulins IgM and IgG3 were not significantly different
between transgene-positive and -negative mice, the se-differentiation of these cells into functional Type 1/2
cells. As can be seen from Figure 5A, activation of T rum levels of T cell±dependent antibodies were much
higher in CD4-dnTGFbRII mice than in wild-type mice.cells from 10-week-old mice with anti-CD3/28 mAbs
demonstrated that while cells from Tg2 mice produced Specifically, the levels of Th2-dependent IgG1 increased
Immunity
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Figure 4. Normal T Cell Development in
Young CD4-dnTGFbRII Tg1 Mice
(A) CD4 and CD8 expression on the thymo-
cytes from 4-week-old transgene-positive
(right panel) or transgene-negative (left panel)
littermates as analyzed by flowcytometry.
(B) Analyses of CD62L and CD44 expression
on CD41 (top panel) and CD81 (bottom panel)
T cells in the lymph nodes of 4-week-old
mice. Six mice per group have been analyzed
individually, and analyses of a representative
individual mouse per group are presented.
8-fold, Th1-dependent IgG2a increased 4-fold, and prevents ªspontaneousº T cell activation have been un-
TGFb/IL-5-dependent IgA increased 16-fold. These data clear. Since TGFb plays an important role in the regula-
show that even in the presence of TGFb signaling in B tion of MHC levels (Panek et al., 1995; Lee et al., 1997),
cells, the absence of TGFb signaling in T cells leads lack of TGFb1 can lead to the spontaneous upregulation
to disregulation of B cell homeostasis and increased of MHC class I and II on multiple tissues observed in
immunoglobulin secretion. the TGFb1 KO (Geiser et al., 1993). Upregulated expres-
sion of MHC might, in turn, be responsible for abnormal
antigen presentation to T cells and the initiation of self-Discussion
mediated immune response in these mice. Furthermore,
embryonic lethality of more than 50% in the mice (reach-The results presented in this paper demonstrate that
ing 100% in C57BL/6 mice) indicates that TGFb1 is cru-TGFb is directly required to maintain T cell homeostasis
cial for embryonic development. The requirement forand that the abrogation of TGFb signaling in T cells
TGFb1 in the development of the hematopoietic systemleads to T cell differentiation into effector T cells. Fur-
(Martin et al., 1995), and disregulation of hematopoiesisthermore, we showed that the lack of TGFb signaling
in adult mice (Letterio et al., 1996; Yaswen et al., 1996),in T cells leads to inflammatory infiltration in multiple
makes it very difficult to study the role of TGFb in regula-organs, immunopathology, and secretion of autoim-
tion of the immune system using TGFb1 KO animals.mune antibodies.
Another complicating factor in studying the role of TGFbThe important role of TGFb in immune homeostasis
in immune regulation using TGFb1 KO mice is the possi-has been previously suggested by the observation of
bility that TGFb1 plays an important role in mitochondrialmultifocal immune-mediated inflammation in TGFb1 KO
metabolism, as demonstrated by the increase in themice (Shull et al., 1992; Kulkarni et al., 1993) similar to
number of mitochondria and the decrease in mitochon-that which we describe in CD4-dnTGFbRII transgenic
drial membrane potential in cells of TGFb1 KO micemice. Although the phenotype of TGFb1 KO mice dem-
(Williams et al., 1996). The reduced mitochondrial poten-onstrated the importance of TGFb in the maintenance
of T cell homeostasis, the mechanisms whereby TGFb tial could adversely effect cellular metabolism and make
Abrogation of TGFb Signaling in T Cells
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Figure 5. Most T Lymphocytes in Old CD4-
dnTGFbRII Tg1 Mice Differentiate into Type
1 or 2 Cytokine-Secreting Cells
(A) Total spleen cells from 3-month-old Tg1
or Tg2 animals were stimulated for 24 hr with
anti-CD3 (0.1 mg/ml) and anti-CD28 (0.5 mg/
ml) mAbs. Cytokines in culture supernatants
were assayed using ELISA.
(B) Spleen cells from 5-month-old Tg2 (left
panel) or Tg1 (right panel) littermates were
stimulated with PMA/ionomycin for 4 hr, with
monensin added for the last 2 hr of stimula-
tion culture. Afterward cells were stained for
CD4 and CD8 and fixed/permeabilized prior
to the staining with fluorescent anti-IFNg and
anti-IL-4 mAbs. Cells were analyzed by flow
cytometry for the IFNg and IL-4 expression
in either CD41 (top panel) or CD81 (bottom
panel) T cells. Five mice per group have been
analyzed individually, and representative re-
sults of the analyses of lymphocytes from an
individual mouse in each group are pre-
sented. Very similar results were obtained us-
ing lymph node cells.
cells more susceptible to apoptosis, thus contributing 1995). Further studies using MHC class II KO narrowed
down CD41 T cells as mediators of multifocal inflamma-to the lethality of mice. It is also important to note that
TGFb1 KO mice still express TGFb2 and TGFb3. These tory infiltration and autoantibody secretion (Letterio et
al., 1996). Although this study did not address the rolecytokines could provide some compensation for the lack
of TGFb1, thus further compounding the interpretation of TGFb in regulation of CD81 T cells, the substantially
longer life span of SCID TGFb1 KO mice versus MHCof the role of TGFb in regulation of T cells based on
the results obtained from TGFb1 KO mice. The above class II/TGFb1 double-KO mice indicates that there may
be some involvement of CD81 T cells in mediating thementioned drawbacks of the TGFb1 KO mice make them
an impractical model to study TGFb regulation of the lethality of TGFb1 KO mice. While both of those studies
established the causative role of T cells in mediatingimmune response in general and of T cells in particular.
Since TGFb signaling in CD4-dnTGFbRII mice is af- pathological inflammatory lesions developed as a result
of TGFb1 deficiency, due to the limitations of TGFb1fected only in T cells and is normal in all other cell types,
these mice lack most of the problems associated with KO system delineated above, both of these studies were
incapable of demonstrating the causative role of T cellsthe use of TGFb1 KO mice as a model for dissecting the
role of TGFb signaling in T cells. It is therefore possible to in initiating the pathological inflammatory response in
that system. Using transgenic mice with T cell±specificconclude from our results that disregulation of TGFb
signaling in T cells is sufficient to break their homeosta- ablation of TGFb signaling, we conclude that lack of
TGFb signaling in T cells alone is sufficient to induce Tsis and cause their activation. Furthermore, we show
that T cell±specific blockade of TGFb signaling leads to cell±mediated multifocal inflammatory lesions and auto-
antibody secretion. Although both CD41 and CD81 cellsautoimmune disease characterized by multifocal inflam-
matory infiltration and autoantibody secretion. The im- are refractory to TGFb signaling in CD4-dnTGFbRII
mice, the results of Letterio et al. (1996) indicating thatportance of T and B lymphocytes in autoimmune disease
caused by the lack of TGFb1 has been previously dem- CD41 T cells are the major mediators of inflammation in
TGFb1 KO mice, taken together with our results, suggestonstrated using TGFb1 KO SCID mice (Diebold et al.,
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Figure 6. Increase in the Levels of T Cell±Dependent Classes of Immunoglobulins in Sera of CD4-dnTGFbRII Mice
Four 4-fold dilutions of sera from seven 5- to 6-month-old CD4-dnTGFbRII mice or five wild-type littermates were assayed for the levels of
IgM, IgG3, IgG1, IgG2, and IgA using ELISA. The results are presented as an average value for all mice in a group 6 SE. An asterisk indicates
statistically significant increase (p , 0.01) in the immunoglobulin level in transgene-positive mice.
that CD41 cells but perhaps not CD81 cells are the likely slowing down the development of autoimmune disease
in these mice. Nevertheless, even if such low-level TGFbmediators and also initiators of the immune-mediated
inflammation in the absence of TGFb signaling in T cells. signaling does occur in T cells from transgenic mice,
that still would not change our conclusions, which areNevertheless, to address this issue unequivocally, we
will need to cross CD4-dnTGFbRII mice with various KO based on the finding in these mice that TGFb signaling in
T cells is required for maintenance of T cell homeostasis.mice.
TGFb1 KO mice develop multifocal inflammation at a The presence of TGFb in the lymphocyte environment
is essential for maintenance of T cell homeostasis, asmuch faster rate and severity than CD4-dnTGFbRII mice.
The more severe autoimmune phenotype observed in we demonstrate that in the absence of TGFb signaling,
T cells spontaneously differentiate into effector cellsTGFb1 KO mice relative to that in CD4-dnTGFbRII mice
could be caused by the abnormal upregulation of MHC capable of effector cytokine secretion and the provision
of help to B cells. Our results illustrate that even thoughclass I and II molecules in tissues of these mice as a
consequence of lack of TGFb control on MHC expres- adult wild-type mice contain a substantial percentage
of effector/memory T cells (as determined by CD44 andsion. Furthermore, disregulated homeostasis of multiple
tissues in the absence of TGFb1 could result in exposure CD62L expression), it appears that a far smaller percent-
age of cells is capable of secreting effector cytokinesand presentation of self-antigens that are normally not
presented. The abnormal self-antigen presentation to T such as IL-4 and IFNg (as determined by intracellular
cytokine staining analysis). These results indicate thatcells, together with the lack of TGFb control of T cells,
could lead to the accelerated and more severe autoim- in normal mice not all T cells that have undergone the
activation process under normal conditions have dif-mune response in those mice relative to CD4-dnTGFbRII
mice, where TGFb signaling is blocked only in T cells. ferentiated into effector T cells. On the other hand, in
the absence of TGFb signaling, most of the T cellsAlternatively, it is possible that we do not achieve
complete blockade of TGFb signaling in T cells of both from CD4-dnTGFbRII mice have differentiated in vivo
into effector T cells capable of secreting IL-4 and/ortransgenic lines that we derived and studied. Although
the signal transduction and T cell activation studies that IFNg. In addition to the acquisition of cytokine secret-
ing properties, these T cells acquired effector functionwe performed did not reveal any ªleakageº of dominant-
negative TGFbRII, we cannot exclude the possibility that as indicated by our finding of increased levels of T
cell±dependent immunoglobulin levels. Indeed, CD4-our tests are not sensitive enough to detect some resid-
ual TGFb signaling that may still play a role in preventing dnTGFbRII mice demonstrated elevated serum immuno-
globulin levels for both Th1- and Th2-dependent IgGspontaneous activation of self-reactive T cells, thereby
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179
from dnTGFbRII. This primer pair amplifies an approximately 300subclasses relative to that in wild-type mice. It is also
bp product from the cDNA sequence; the genomic DNA sequenceinteresting to note that CD4-dnTGFbRII mice exhibit an
is 2400 bp longer because of an intron sequence. b-actin primerselevated level of serum IgA. This contrasts with the
were used as a positive control for cDNA loading; the sequence of
TGFb1 KO mice, which in agreement with the require- b-actin primers was as described (Gorelik and Mokyr, 1995).
ment for TGFb in IgA class switching (Kim and Kagnoff,
1990; McIntyre et al., 1995) exhibit decreased levels of Cell Purification and Culture
IgA relative to wild-type mice (van Ginkel et al., 1999). CD41 or CD81 T cells were enriched from spleen and lymph node
cells by negative selection through the depletion using anti-MHCThis result confirms that B cells in CD4-dnTGFbRII mice
class II (M1/115), anti-NK1.1 (HB191), anti-FcRII (2.4G2), and anti-are responsive to TGFb and indicates that there is prob-
CD8 (53-6.7) or anti-CD4 (GK1.5) mAbs, respectively, followed byably an increase in T cell production of TGFb in these
depletion with a mixture of magnetic beads conjugated to anti-ratanimals. Ig and anti-mouse Ig antibodies (PerSeptive Biosystems). The purity
Although we currently do not know the nature of the of cells was usually greater than 90%. For some experiments
activating stimuli that drive activation and differentiation cells were purified using a cell sorter (Becton Dickinson) by gating
on B2201TCRab2 (B2201 cells), CD41CD44low (CD41 cells) orof T cells in the absence of TGFb signaling in CD4-
CD81CD44low (CD81 cells); in that case, the purity of cells was .99%.dnTGFbRII mice, the presence of autoimmune IgG anti-
All mAbs used for staining were from PharMingen. Essentially thebodies in these mice (Figure 2B) indicates that at least
same results were obtained using cells enriched by magnetic beadssome of the T cell response is directed against self- or cells sorted by FACS.
antigens. Since TGFb signaling is not affected in B For analyses of Smad2 phosphorylation, 2 3 106 cells of indicated
cells in CD4-dnTGFbRII mice, the presence of T cell± cell populations were incubated with 3 ng/ml TGFb1 (R&D Systems)
in 1 ml complete culture media for 30 min. Afterward, Na3VO4 wasdependent subclasses of autoantibodies indicates that
added to culture medium, and cells were harvested, pelleted, andB cell tolerance depends on T cell tolerance. This sug-
lysed in lysis buffer (300 mM Tris, 50 mM NaCl, 0.5% Triton X)gests that B cells do recognize and present self-antigen
containing Complete protease inhibitor cocktail (Boehringer-Man-under normal nonpathological conditions, and that these heim) and 1 mM Na3VO4 (Sigma).
B cells will get activated and produce autoantibodies For the cell proliferation assay, 96-well plates (Falcon) were pre-
provided they encounter autoreactive T cells such as coated with 5 mg/ml anti-CD3 mAb (2C11) and 10 mg/ml anti-CD28
mAb (37.51) in 20 ml PBS per well for at least 1 hr at 378C or overnightthose in our transgenic mice. Although B cell tolerance
at 48C. The antibody solution was aspirated, and 105 CD41 or CD81to self-antigen has been demonstrated in several sys-
cells per well were placed in 200 ml complete media per well withtems and was proposed to be an important mechanism
or without 3 ng/ml recombinant human TGFb1, TGFb2, or TGFb3for maintenance of self-tolerance, our data support the (all three cytokines are from R&D Systems). For B cell proliferation
hypothesis that T cells are more sensitive than B cells analyses, we stimulated 2 3 105 total spleen cells or B2201 cells
to tolerance induction to self-antigens and that breaking per well with 10 mg/ml LPS (Sigma) in 200 ml complete culture media
with or without 3 ng/ml TGFb1. Cells were stimulated for 72 hr (forof T cell tolerance to self-antigen is sufficient to break
T cells) or for 48 hr (for B cells), 1 mCi/well of [3H]thymidine (Amer-B cell tolerance and induce a B cell±mediated self-
sham) was added for the last 8±10 hr of cell culture. Backgrounddirected immune-response (Adelstein et al., 1991; Ak-
counts of cells alone without any stimulation were lower then 800karaju et al., 1997). Indeed, it seems that much higher cpm.
doses of antigen are required to induce B cell tolerance For cytokine production measurements, 2 3 106 spleen cells were
directly (Adelstein et al., 1991). stimulated by addition of 0.1 mg/ml anti-CD3 mAb and 0.5 mg/ml
anti-CD28 mAb in 2 ml complete media per well in 24-well platesThe results of this paper demonstrate the important
(Falcon). After 24 hr, supernatants were collected and assayed forrole of TGFb in the regulation of T cell homeostasis and
cytokine levels by ELISA.prevention of immune inflammation in many organs. We
also provide evidence that TGFb is an important anti-
Histopathology and Immunohistochemistrydifferentiation factor for T cells under physiological con-
Animals were sacrificed and selected tissues were fixed in 10%
ditions in vivo. In addition, CD4-dnTGFbRII mice provide formalin (Sigma) and embedded in paraffin. Five micrometer sec-
a good model to study the regulation of various immune tions were stained with hematoxylin and eosin and analyzed. For
responses in the absence of TGFb signaling in T cells. detection of IgG deposits in kidney glomeruli, kidneys were frozen in
OCT media and stored at 2708C. Four micrometer cryostat sections
were cut and fixed in acetone for 10 min. Kidney sections wereExperimental Procedures
stained with FITC-labeled goat anti-mouse IgG (SBA) or FITC-
labeled goat anti-rabbit IgG (Santa Cruz) as a negative control. Pic-Plasmids and Transgenic Mice
tures were taken using a Zeiss Axiovert 25 microscope and a SonyThe human TGFb type II receptor sequence between nucleotides
DXC-9000 3CCD color camera.27 and 1573, which encodes the extracellular and transmembrane
portions of the TGFb type II receptor (Bottinger et al., 1997), was
a generous gift from L. Wakefield. The dnTGFbRII fragment was Western Blot
amplified using primers with flanking SalI restriction sites and cloned For the analysis of Smad2 expression, total cell lysates of indicated
into the SalI site of plasmid CD4 promoter vector p37.1 (a gift of D. cell populations were separated on 10% SDS gel transferred to
Littman). The sequence of dnTGFbRII was confirmed by sequencing. PVDF membrane (Millipore) and probed with anti-phospho-Smad2
In order to generate transgenic mice, the CD4-dnTGFbRII fragment (Ser465/467) Ab (Upstate Biotechnology). Amounts of protein were
containing CD4 promoter, dnTGFbRII and polyadenylation se- determined by Bio-Rad protein assay to ensure equal protein load-
quence was excised by NotI, purified, and injected into (C57BL/ ing for the analysis. Subsequently, the membrane was striped with
6xC3H)F1 fertilized eggs. Founder mice were identified using PCR 0.1 M Glycine (pH 2.5) for 30 min at room temperature and reprobed
and backcrossed at least three times onto B10.BR background for with antibodies to total Smad2 (Transduction Laboratories) and
further experiments. b-actin (Santa Cruz).
For the analysis of the presence of anti-ribonuclear protein anti-
bodies in the serum of mice, nuclear extracts were prepared fromRNA Analysis
Total spleen cell RNA was extracted using TRIzol (GIBCO±BRL) and the purified CD41 T cells as described (Schreiber et al., 1989). Ten
micrograms of nuclear extract per lane was separated on 12% SDSreverse transcribed using Superscript II (GIBCO±BRL). PCR was
performed using forward primer from CD4 exon 1 and reverse primer gel, transferred to PVDF membrane, and individual strips were
Immunity
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probed with serum (1:150 dilution) from 5-month-old transgene- Induction of self-tolerance in T cells but not B cells of transgenic
mice expressing little self antigen. Science 251, 1223±1225.negative and -positive mice. Nuclear protein±specific antibodies
were visualized with rabbit HRP-conjugated anti-mouse IgG Ab (Am- Akkaraju, S., Canaan, K., and Goodnow, C.C. (1997). Self-reactive
ersham). The immune complexes were detected using ECL system B cells are not eliminated or inactivated by autoantigen expressed
(Pierce). on thyroid epithelial cells. J. Exp. Med. 186, 2005±2012.
Amendt, C., Schirmacher, P., Weber, H., and Blessing, M. (1998).
FACS Analyses Expression of a dominant negative type II TGF-beta receptor in
Cells (106) from spleen, lymph nodes, or thymus were first preincu- mouse skin results in an increase in carcinoma incidence and an
bated with 2.4G2 mAb to block FcgR and then incubated with indi- acceleration of carcinoma development. Oncogene 17, 25±34.
cated antibodies for 30 min on ice. The samples were washed and Arai, K.-I., Sporn, M.B., Roberts, A.B., and Battey, J.F. (1990). Pep-
analyzed on FACSCalibur (Becton Dickinson), and 20,000 live cell tide Growth Factors and Their Receptors (Berlin; New York:
events were collected. The analyses were conducted using CELL- Springer-Verlag).
quest (Becton Dickinson) or FloJo (Tree Star) analysis software. All
Bottinger, E.P., Jakubczak, J.L., Haines, D.C., Bagnall, K., and Wake-
antibodies used for staining were obtained from PharMingen.
field, L.M. (1997). Transgenic mice overexpressing a dominant-neg-
For intracellular cytokine staining, single-cell suspensions of
ative mutant type II transforming growth factor beta receptor show
spleen or lymph node cells were stimulated with 50 ng/ml PMA
enhanced tumorigenesis in the mammary gland and lung in re-
(Sigma) and 1 mM ionomycine (Sigma) for 4 hr; monensin (Phar-
sponse to the carcinogen 7,12-dimethylbenz-[a]-anthracene. Can-
Mingen) was added for the last 2 hr of stimulation culture. After
cer Res. 57, 5564±5570.
stimulation, cells were stained with a mixture of Cy-Chrome-labeled
Chen, R.H., Ebner, R., and Derynck, R. (1993). Inactivation of theanti-CD4 and biotinylated anti-CD8 mAbs, subsequently fixed and
type II receptor reveals two receptor pathways for the diverse TGF-permeabilized using a Cytofix/Cytoperm kit (PharMingen), and then
beta activities. Science 260, 1335±1338.stained using FITC-labeled anti-IFNg mAb and PE-labeled anti-IL-4
Christ, M., McCartney-Francis, N.L., Kulkarni, A.B., Ward, J.M.,mAb and streptavidin-APC (all from PharMingen) according to
Mizel, D.E., Mackall, C.L., Gress, R.E., Hines, K.L., Tian, H., Karlsson,manufacture's recommendations. Isotype matched FITC- and PE-
S., et al. (1994). Immune dysregulation in TGF-beta 1-deficient mice.labeled mAb were used as negative control for intracellular cytokine
J. Immunol. 153, 1936±1946.staining. Fifty-thousand events were collected, and after gating on
CD41 or CD81 cells, intracellular cytokine staining was analyzed. Cousins, S.W., McCabe, M.M., Danielpour, D., and Streilein, J.W.
Gates for cytokine staining were set using isotype-matched control (1991). Identification of transforming growth factor-beta as an immu-
antibody staining. nosuppressive factor in aqueous humor. Invest. Ophthalmol. Vis.
Sci. 32, 2201±2211.
Diebold, R.J., Eis, M.J., Yin, M., Ormsby, I., Boivin, G.P., Darrow,ELISA
B.J., Saffitz, J.E., and Doetschman, T. (1995). Early-onset multifocalCytokine levels in tissue culture supernatants were assayed using
inflammation in the transforming growth factor beta 1-null mouse isELISA antibody pairs for IL-2, IL-4, and IFNg (PharMingen) according
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